SCHEMBL25879759

SCHEMBL25879759

CCOC(=O)Cc1ccc(CO)cc1N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 4/20 0.43
CYP4A11 Q02928 4/20 0.43
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
GFER P55789 1/20 0.41
PKM P14618 1/20 0.40
CYP4Z1 Q86W10 1/20 0.40
PPIB P23284 1/20 0.40
PPIA P62937 1/20 0.40
PPID Q08752 1/20 0.40
PPIG Q13427 1/20 0.40
CHEK1 O14757 1/20 0.39
CA12 O43570 1/20 0.39
CA2 P00918 1/20 0.39
CA3 P07451 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA14 Q9ULX7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5201332 0.91 ALDH1A1 (0.50) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL5201334 0.87 GAA (0.43) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL5100488 0.86 ALDH1A1 (0.51) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL21824092 0.84 CYP4F2 (0.55) CYP4F2CYP4A11ALDH1A1GAACYP4Z1
SCHEMBL2131319 0.83 LMNA (0.46) ALDH1A1PKMPPIBPPIAPPID
SCHEMBL21437852 0.83 NLRP3 (0.43) ALDH1A1GAAPKMCHEK1SMN1; SMN2
SCHEMBL20383846 0.81 PKM (0.42) ALDH1A1PKMCHEK1SMN1; SMN2EGFR
SCHEMBL13634975 0.80 SLC6A2 (0.43) CYP4F2CYP4A11ALDH1A1GAAGFER
SCHEMBL21438181 0.79 ALDH1A1 (0.49) ALDH1A1GAASMN1; SMN2MAPTDPP4
SCHEMBL10687240 0.79 CREBBP (0.55) ALDH1A1PKMCHEK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11708347-B2 Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors BIOCRYST PHARMACEUTICALS, INC. (US) 2023-07-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11708347-B2 Substituted benzofuran, benzopyrrole, benzothiophene, and structurally related complement inhibitors C9, C5, C1QBP CYP4F2 29/4885CYP4A11 961/4885ALDH1A1 1047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.